Professor | 史亮 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	史亮
Contact Information	liang_shi@zju.edu.cn
Language ability	中文, 英语
Province	浙江

Upload Avatar (500 x 500)

Name

史亮

Contact Information

liang_shi@zju.edu.cn

Language ability

中文, 英语

Province

浙江

University/Lab Affiliation and Title	浙江大学
Faculty	Medical
Academic Background & Achievements	外科学博士: 浙江大学博士后研究: 美国罗切斯特大学癌症研究所博士后研究: 浙江大学优秀博士后: 浙江省典型博士后代表: 浙江省
Work Experience	现任 - 浙江大学医学院附属邵逸夫医院 - 普外科主治医师，特聘副研究员现任 - 浙江大学 - 外科学硕士生导师
Awards	优秀博士后: 浙江省典型博士后代表: 浙江省

University/Lab Affiliation and Title

浙江大学

Faculty

Medical

Academic Background & Achievements

外科学博士: 浙江大学
博士后研究: 美国罗切斯特大学癌症研究所
博士后研究: 浙江大学
优秀博士后: 浙江省
典型博士后代表: 浙江省

Work Experience

现任 - 浙江大学医学院附属邵逸夫医院 - 普外科主治医师，特聘副研究员
现任 - 浙江大学 - 外科学硕士生导师

Awards

优秀博士后: 浙江省
典型博士后代表: 浙江省

Areas of Focus	肝胆胰良恶性疾病的基础研究与临床转化表观调控相关的免疫微环境与肿瘤转移环状RNA在疾病中的功能机制
Publications	Cytoskeleton remodeling-mediated-by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer, Liu Boqiang, Shen Hao, He Jing, Jin Binghan, Tian Tuanshi, Li Weiai, Hou Lidan, Zhao Weijun, Nan Junjie, Zhao Jia, Shen Jiliang, Yu Hong, Wang Yifan, Shan Ge, Shi Liang, Cai Xiujun, 2023 A tumor-suppressive circular RNA mediates uncanonical integrin degradation by the proteasome in liver cancer, Shi L, Liu B, Shen DD, Yan P, Zhang Y, Tian Y, Hou L, Jiang G, Zhu Y, Liang Y, Liang X, Shen B, Yu H, Zhang Y, Wang Y, Guo X, Cai X, 2021 Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer, Shen H, Liu B, Xu J, Zhang B, Wang Y, Shi L, Cai X, 2021 Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals, Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Lin C, Yeh S, Cai X, Chang C, 2016 Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma, Shi L, Yan P, Liang Y, Sun Y, Shen J, Zhou S, Lin H, Liang X, Cai X, 2017 Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression, Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C, 2016 Role of estrogen in hepatocellular carcinoma: is inflammation the key?, Shi L, Feng Y, Lin H, Ma R, Cai X, 2014 Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma, Jiang G, Shi L, Zheng X, Zhang X, Wu K, Liu B, Yan P, Liang X, Yu T, Wang Y, Cai X, 2020 The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review, Juengpanich S, Shi L, Iranmanesh Y, Chen J, Cheng Z, Khoo AK, Pan L, Wang Y, Cai X, 2019 The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis, Liu B, Tian Y, He J, Gu Q, Jin B, Shen H, Li W, Shi L, Yu H, Shan G, Cai X, 2022 Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals, Xu J, Lin H, Li G, Sun Y, Shi L, Ma WL, Chen J, Cai X, Chang C, 2017 The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals, Xu J, Lin H, Li G, Sun Y, Chen J, Shi L, Cai X, Chang C, 2016 CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular Carcinoma, Liu B, Tian Y, Chen M, Shen H, Xia J, Nan J, Yan T, Wang Y, Shi L, Shen B, Yu H, Cai X, 2021 A retrospective pilot study to examine the feasibility of real-time navigation for laparoscopic liver resections in intrahepatic cholangiocarcinoma using fusion indocyanine green fluorescence imaging, Zhai ST, Liang X, Mao QJ, Liang YL, Xu JJ, Chen J, Shi L, Xie YY, Cai XJ, 2020 TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression, Jin R, Lin H, Li G, Xu J, Shi L, Chang C, Cai X, 2018 Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy, Shen J, Zhang Y, Yu H, Shen B, Liang Y, Jin R, Liu X, Shi L, Cai X, 2016

Areas of Focus

肝胆胰良恶性疾病的基础研究与临床转化
表观调控相关的免疫微环境与肿瘤转移
环状RNA在疾病中的功能机制

Publications

Cytoskeleton remodeling-mediated-by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer, Liu Boqiang, Shen Hao, He Jing, Jin Binghan, Tian Tuanshi, Li Weiai, Hou Lidan, Zhao Weijun, Nan Junjie, Zhao Jia, Shen Jiliang, Yu Hong, Wang Yifan, Shan Ge, Shi Liang, Cai Xiujun, 2023
A tumor-suppressive circular RNA mediates uncanonical integrin degradation by the proteasome in liver cancer, Shi L, Liu B, Shen DD, Yan P, Zhang Y, Tian Y, Hou L, Jiang G, Zhu Y, Liang Y, Liang X, Shen B, Yu H, Zhang Y, Wang Y, Guo X, Cai X, 2021
Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer, Shen H, Liu B, Xu J, Zhang B, Wang Y, Shi L, Cai X, 2021
Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals, Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Lin C, Yeh S, Cai X, Chang C, 2016
Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma, Shi L, Yan P, Liang Y, Sun Y, Shen J, Zhou S, Lin H, Liang X, Cai X, 2017
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression, Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C, 2016
Role of estrogen in hepatocellular carcinoma: is inflammation the key?, Shi L, Feng Y, Lin H, Ma R, Cai X, 2014
Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma, Jiang G, Shi L, Zheng X, Zhang X, Wu K, Liu B, Yan P, Liang X, Yu T, Wang Y, Cai X, 2020
The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review, Juengpanich S, Shi L, Iranmanesh Y, Chen J, Cheng Z, Khoo AK, Pan L, Wang Y, Cai X, 2019
The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis, Liu B, Tian Y, He J, Gu Q, Jin B, Shen H, Li W, Shi L, Yu H, Shan G, Cai X, 2022
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals, Xu J, Lin H, Li G, Sun Y, Shi L, Ma WL, Chen J, Cai X, Chang C, 2017
The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals, Xu J, Lin H, Li G, Sun Y, Chen J, Shi L, Cai X, Chang C, 2016
CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular Carcinoma, Liu B, Tian Y, Chen M, Shen H, Xia J, Nan J, Yan T, Wang Y, Shi L, Shen B, Yu H, Cai X, 2021
A retrospective pilot study to examine the feasibility of real-time navigation for laparoscopic liver resections in intrahepatic cholangiocarcinoma using fusion indocyanine green fluorescence imaging, Zhai ST, Liang X, Mao QJ, Liang YL, Xu JJ, Chen J, Shi L, Xie YY, Cai XJ, 2020
TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression, Jin R, Lin H, Li G, Xu J, Shi L, Chang C, Cai X, 2018
Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy, Shen J, Zhang Y, Yu H, Shen B, Liang Y, Jin R, Liu X, Shi L, Cai X, 2016

肝脏胆囊胰腺良性恶性表观遗传免疫微环境肿瘤转移

黄建 - 浙江大学

陈玮 - 浙江大学

Area of Focus
感染 | 免疫 | 病原体 | 免疫反应 | 疫苗 | 肿瘤 | 癌症 | 免疫治疗 | 自噬 | 蛋白降解

徐芳英 - 浙江大学

Area of Focus
肿瘤 | 病理 | 分子机制 | 肿瘤发生 | 发展 | 微环境 | 癌症 | 转移 | 免疫 | 结直肠

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们